PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-40

  1. 489 Posts.
    lightbulb Created with Sketch. 48
    Fabulous result and a major step forward on the FDA journey. Indeed it’s a massive understatement to say that the next 18 months are going to be a interesting ride for PAR as big Pharma position themselves. Well done to all involved in achieving this major milestone on the roller coaster that is pharmaceutical commercialisation.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.